Comments
Dr Reddy’s Laboratories Ltd has launched Pramipexole dihydrochloride extended-release tablets in the US market.
The drug is a therapeutic equivalent generic version of Mirapex ER (pramipexole dihydrochloride) extended-release tablets. It is a registered trademark of Boehringer Ingelheim Pharma GmbH & Co. KG Corporation. It is indicated in the treatment of Parkinson’s.
The Mirapex ER brand and generic had U.S. sales of approximately $48.3 million for the most recent twelve months ending in June 2015 according to IMS Health.
Dr Reddy’s scrip gained 1.08 per cent on the Bombay Stock Exchange on Wednesday to end at Rs 4,276.70.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.